Latest Security News

Nex Metals Explorations has secured a binding agreement to operate the North Hennai gold project in Egypt’s Eastern Desert, marking its strategic entry into one of the world’s most under-explored mining regions with promising production and exploration potential.

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

Charger Metals has secured approvals for a significant 4,600m drilling campaign at its Lake Johnston Lithium and Gold Project, fully funded by Rio Tinto Exploration. This move aims to build on recent resource milestones and explore new lithium targets in Western Australia.

Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the first half of 2025, with payments available in multiple currencies based on shareholder location.

Hastings Technology Metals and Wyloo have formalised their joint venture for the Yangibana Rare Earths Project, with Wyloo taking a 60% stake and cancelling A$123 million in exchangeable notes, significantly de-risking the project and reducing Hastings’ funding burden.

Resouro Strategic Metals has amended its private placement terms, aiming to raise CAD 3 million to fund engineering work for its Tiros Titanium-Rare Earths Project in Brazil.

Core Energy Minerals has appointed Anthony Greenaway as Managing Director, aiming to leverage his extensive exploration expertise to advance its uranium and rare earth projects in South Australia and Brazil.

Peel Mining has appointed a new leadership team with deep mining and capital markets expertise, aiming to unlock significant value from its copper and polymetallic assets in the prolific Cobar region. The company signals a strategic shift towards targeted exploration, regional consolidation, and disciplined growth.

HealthCo Healthcare & Wellness REIT has collected all outstanding rent from Healthscope and extended a rent deferral to support the ongoing sale process, while suspending distributions to preserve liquidity.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Locksley Resources reports robust metallurgical testwork from its Mojave Project, confirming high antimony recoveries and concentrate grades that support a domestic US supply chain. The results align with US strategic priorities for critical mineral independence.

Brightstar Resources has obtained key regulatory approvals for its Lord Byron open pit project, positioning the company to commence mining operations in the second half of 2026. This milestone advances Brightstar’s strategy to boost gold production from its Laverton Hub.